Gene Therapy for CD19-Positive Hematologic Malignancies (SENTRY-CD19)
מצבים רפואיים
B-cell Acute Lymphoblastic Leukemia · Large B-cell Lymphoma · Chronic Lymphocytic Leukemia · Small Lymphocytic Lymphoma · Marginal Zone Lymphoma · Follicular Lymphoma · Mantle Cell Lymphoma · Diffuse Large B Cell Lymphoma · High-grade B-cell Lymphoma · Burkitt Lymphoma · Primary Mediastinal Large B-cell Lymphoma (PMBCL) · Non Hodgkin Lymphoma · Mixed Phenotype Acute Leukemia
סיכום בשפה פשוטהבעזרת בינה מלאכותית
הסיכום נכתב על־ידי מודל שפה והוא ניסיוני. המידע עלול להיות חלקי או שגוי ואינו תחליף לייעוץ רפואי.
מיקומים
City of Hope, Duarte, California, United States
Contact: Principal Investigator (Anthony Stein, MD)Valkyrie Clinical Trials, Los Angeles, California, United States
Colorado Blood Cancer Institute, Denver, Colorado, United States
New York Medical College, Valhalla, New York, United States
Contact: Principal Investigator (Mitchell Cairo, MD)University of North Carolina at Chapel Hill/ University of North Carolina Medical Center, Chapel Hill, North Carolina, United States
The Ohio State University Wexner Medical Center, Columbus, Ohio, United States
Contact: Study coordinator (Gregory Behbehani, MD, PhD) · gregory.behbehani@osumc.edu · 614-293-3316Oregon Health & Science University, Portland, Oregon, United States
Contact: Study coordinator (Knight Cancer Institute Clinical Trials) · trials@ohsu.edu · 503-949-1080TriStar BMT, Nashville, Tennessee, United States
Contact: Study coordinator (Stephen Strickland, MD) · stephen.strickland@hcahealthcare.com · 615-329-7274University of Texas MD Anderson Cancer Center, Houston, Texas, United States
מובילי המחקר
Vironexis Clinical Trials
Study Director
Vironexis Biotherapeutics Inc.